The mechanism of ellipticine-induced apoptosis and cell cycle arrest in human breast MCF-7 cancer cells

Cancer Letters

Volumn 223, Issue 2, 2005, Pages 293-301

  Kuo, Po Lin ^a   Hsu, Ya Ling ^b   Chang, Cheng Hsiung ^a   Lin, Chun Ching ^b  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Ellipticine; Fas Fas ligand; Mitochondria

Indexed keywords

BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ELLIPTICINE; FAS ANTIGEN; FAS LIGAND; PROTEIN BID; PROTEIN P53;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CARRIER PROTEINS; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ELLIPTICINES; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

MINK CELL FOCUS-FORMING VIRUS;

EID: 19344363980     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.09.046     Document Type: Article

References (19)

1. S. Goodwin, A.F. Smith, and E.C. Horning Alkaloids of Ochrosia elliptica Labill J Am. Chem. Soc. 81 1959 1903 1908
2. Z. Djuric, C.K. Everett, and F.A. Valeriote DNA damage cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(diethylaminoethyl)-9- hydroxyellipticinium chloride Cancer Res. 52 1992 1515 1519
3. M. Monnot, O. Mauffret, V. Simon, E. Lescot, B. Psaume, and J.M. Saucier DNA-drug recognition and effects on topoisomerase II-mediated cytotoxicity. A three-mode binding model for ellipticine derivatives J. Biol. Chem. 266 1991 1820 1829
4. L.M. Shi, T.G. Myers, Y. Fan, P.M. O'Connor, K.D. Paull, S.H. Friend, and J.N. Weinstein Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity Mol. Pharmacol. 53 1998 241 251
5. R. Devraj, J.F. Barrett, J.A. Fernandez, J.A. Katzenellenbogen, and M. Cushman Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates J. Med. Chem. 39 1996 3367 3374
6. 2-methylellipticinium acetate in human brain and non-brain tumor cell lines Biochem. Pharmacol. 49 1995 23 32
7. W.K. Anderson, A. Gopalsamy, and P.S. Reddy Design, synthesis, and study of 9-substituted ellipticine and 2-methylellipticinium analogues as potential CNS-selective antitumor agents J. Med. Chem. 37 1994 1955 1963
8. J. Kattan, M. Durand, J.P. Droz, M. Mahjoubi, J.P. Marino, and M. Azab Phase I study of retelliptine dihydrochloride (SR 95325 B) using a single two-hour intravenous infusion schedule Am. J. Clin. Oncol. 17 1994 242 245
9. M. Hagg, M. Berndtsson, A. Mandic, R. Zhou, M.C. Shoshan, and S. Linder Induction of endoplasmic reticulum stress by ellipticine plant alkaloids Mol. Cancer Ther. 3 2004 489 497
10. M.O. Hengartner The biochemistry of apoptosis Nature 407 2000 770 776
11. T. Suda, T. Takahashi, P. Golstein, and S. Nagata Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 75 1993 1169 1178
12. Y. Pommier, O. Sordet, S. Antony, R.L. Hayward, and K.W. Kohn Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks Oncogene 23 2004 2934 2949
13. I. Herr, and K.M. Debatin Cellular stress response and apoptosis in cancer therapy Blood 98 2001 2603 2614
14. C. Gajate, F. An, and F. Mollinedo Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95- and mitochondrial- mediated mechanism Clin. Cancer Res. 9 2003 1535 1545
15. M.D. Mediavilla, S. Cos, and E.J. Sanchez-Barcelo Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro Life Sci. 65 1999 415 420
16. F. Castaneda, and R.K. Kinne Apoptosis induced in HepG2 cells by short exposure to millimolar concentrations of ethanol involves the Fas-receptor pathway J. Cancer Res. Clin. Oncol. 127 2001 418 424
17. Y. Peng, C. Li, L. Chen, S. Sebti, and J. Chen Rescue of mutant p53 transcription function by ellipticine Oncogene 22 2003 4478 4487
18. E. Sugikawa, T. Hosoi, N. Yazaki, M. Gamanuma, N. Nakanishi, and M. Ohashi Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine Anticancer Res. 19 1999 3099 3108
19. M. Ohashi, E. Sugikawa, and N. Nakanishi Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism Jpn. J. Cancer Res. 86 1995 819 827